OXZGEN Performance 25 mg Hemp Derived CBD + Teacrine + BCAA Orange Flavored, 5 blast caps, 2.2…
Recalling firm: Hall Global, LLC
Yellow #6 is not declared on ingredient label. Label claim for B2 is incorrect (contains 5 mg not 10 mg as stated).
Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Feb 20, 2020.
Check your package
Compare the exact product and package details with the label you have.
FDA code information
10097902, 10186904, 10235905, and 10278906
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
OXZGEN Performance 25 mg Hemp Derived CBD + Teacrine + BCAA Orange Flavored, 5 blast caps, 2.2 FL OZ
Original FDA recall reason
Yellow #6 is not declared on ingredient label. Label claim for B2 is incorrect (contains 5 mg not 10 mg as stated).
Recall details
- Recall number
- F-0070-2020
- Event ID
- 83891
- FDA status
- Terminated
- Initiated
- Sep 25, 2019
- Reported
- Oct 30, 2019
- Classified
- Oct 24, 2019
- Terminated
- Feb 20, 2020
- Quantity
- 1007 packages of 5 count caps
- Location
- Southlake, TX, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Where it was distributed
Contract Manufacturer sends products to distribution centers owned by clients or direct to client company for distribution via internet to end product user.
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.